Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania

Journal of Infectious Diseases

Volumn 193, Issue 12, 2006, Pages 1738-1741

  Alifrangis, Michael ^a,e   Dalgaard, Michael B ^a   Lusingu, John P ^b,c   Vestergaard, Lasse S ^a   Staalsoe, Trine ^a   Jensen, Anja T R ^a   Enevold, Anders ^a   Rønn, Anita M ^a   Khalil, Insaf F ^a   Warhurst, David C ^d   Lemnge, Martha M ^b   Theander, Thor G ^a,c   Bygbjerg, Ib C ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^c Joint Malaria Programme   (Tanzania)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOQUINOLINE; AMODIAQUINE; CHLOROQUINE;

AFRICA; ANTIBIOTIC RESISTANCE; ARTICLE; CHLOROQUINE RESISTANCE TRANSPORTER GENE; ENDEMIC DISEASE; GENE; GENE FREQUENCY; HAPLOTYPE; NONHUMAN; PLASMODIUM FALCIPARUM; PREVALENCE; PRIORITY JOURNAL; TANZANIA;

ADOLESCENT; AMODIAQUINE; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; GENE FREQUENCY; HAPLOTYPES; HUMANS; MALARIA, FALCIPARUM; MEMBRANE PROTEINS; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; TANZANIA;

EID: 33744819146     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/504269     Document Type: Article

References (17)

1. Mutabingwa TK. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy! Acta Trop 2005; 95:305-15.
2. Mutabingwa TK, Anthony D, Heller A, et al. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet 2005; 365: 1474-80.
3. Holmgren G, Gil JP, Ferreira PM, Veiga MI, Obonyo CO, Bjorkman A. Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infect Genet Evol (in press).
4. Fidock DA, Nomura T, Talley AK, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 2000; 6:861-71.
5. Djimde A, Doumbo OK, Cortese JF, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 2001; 344:257-63.
6. Djimde AA, Doumbo OK, Traore O, et al. Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg 2003; 69:558-63.
7. Khalil IF, Alifrangis M, Tarimo DS, et al. The roles of the pfcrt 76T and pfmdr1 86Y mutations, immunity and the initial level of parasitaemia, in predicting the outcome of chloroquine treatment in two areas with different transmission intensities. Ann Trop Med Pa itol 2005; 99:441-8.
8. Ochong EO, van den Broek IV, Keus K, Nzila A. Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan. Am J Trop Med Hyg 2003; 69:184-7.
9. Warhurst DC. Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine. Malar J 2003; 2:31.
10. Cooper RA, Hartwig CL, Ferdig MT. pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective. Acta Trop 2005; 94:170-80.
11. Sidhu AB, Verdier-Pinard D, Fidock DA. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 2002; 298:210-3.
12. Alifrangis M, Enosse S, Pearce R, et al. A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction and enzyme linked immunosorbent assay-based technology. Am J Trop Med Hyg 2005; 72:155-62.
13. Jensen AT, Magistrado P, Sharp S, et al. Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP 1 encoded by group A var genes. J Exp Med 2004; 199:1179-90.
14. Mita T, Kaneko A, Lum JK, et al. Expansion of wild type allele rather than back mutation in pfcrt explains the recent recovery of chloroquine sensitivity of Plasmodium falciparum in Malawi. Mol Biochem Parasitol 2004; 135:159-63.
15. Severini C, Menegon M, Sannella AR, et al. Prevalence of pfcrt point mutations and level of chloroquine resistance in Plasmodium falciparum isolates from Africa. Infect Genet Evol (in press).
16. Lemnge MM, Alifrangis M, Kafuye M, et al. High re-infection rate and treatment failures in children treated with amodiaquine for Falciparum malaria in Muheza villages, North-Eastern Tanzania. Am J Trop Med Hyg (in press).
17. Vathsala PG, Pramanik A, Dhanasekaran S, et al. Widespread occurrence of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene haplotype SVMNT in P. falciparum malaria in India. Am J Trop Med Hyg 2004; 70:256-9.